Objective: The spectrum of molecular defects in Chinese patients with 21-hydroxylase deficiency (21-OHD), and genotype-phenotype relationships are unknown. Methods: We screened eight patients with non-classical (NC) 21-OHD and 35 with classical 21-OHD, and detected nine known mutations.
Introduction
Congenital adrenal hyperplasia (CAH), caused by a deficiency of steroid 21-hydroxylase (CYP21A2), is one of the most common autosomal recessive diseases. Its incidence was reported to be around 1 in 28,000 in Taiwan, 1 but ranges from 1 in 10,000 to 1 in 15,000 live births in most other populations. 2 It causes ambiguous genitalia at birth in females and inefficient cortisol synthesis in both genders. Three major phenotypes of CAH from 21-hydroxylase deficiency (21-OHD) are described: the classical salt-wasting form (SW), the classical simple virilizing form at birth (SV), and the non-classical form with late-onset symptoms and diagnosis (NC21-OHD).
The molecular defects in Chinese patients with NC21-OHD have not been identified. Therefore, in the present study, we used a rapid mutation analysis method to ascertain the prevalence of nine common mutations in CYP21A2 (complete allele deletion [Del] ; c.328delGAGACTAC in exon 3 [E3Á8bp]; p.Gln318Ter in exon 8; p.Arg356Trp in exon 8; the exon 6 p.[Ile236Asn; Val237Glu; Met239Lys] cluster; c.290-13A/ C > G in intron 2; p.Ile172Asn in exon 4; p.Pro30Leu in exon 1; and p.Val281Leu in exon 7). We also analyzed genotypephenotype correlations in Chinese patients with 21-OHD. [2] [3] [4] [5] Patients and methods
Study population
Eight female NC21-OHD patients aged 16.5 AE 4.5 years, and 35 classical 21-OHD patients (nine SW and 26 SV; 10 males and 25 females) aged 14.5 AE 10.0 years who were seen at the Department of Endocrinology, Peking Union Medical College Hospital were included in the study. The diagnosis was made according to clinical manifestations and the 17-hydroxyprogesterone (17-OHP) assay. 5 Polycystic ovary (PCO) was diagnosed by ultrasound examination as either 12 or more follicles measuring 2 AE 9 mm in diameter, or an increased ovarian volume (>10 cm 3 ). 6 All subjects were unrelated Han Chinese who lived in northern China (provinces above the Yangtze River). All adult patients signed an informed consent form for DNA analysis. Parents/ guardians signed an informed consent form for children. The study was approved by the Ethics Committee of the Peking Union Medical College Hospital.
Molecular analysis
Genomic DNA was prepared from peripheral blood leukocytes using a QIAamp DNA Blood Mini Kit according to the manufacturer's instructions (Qiagen, Hilden, Germany).
CYP21A2 Del detection
PCR amplification of CYP21A2 in several fragments was performed using oligonucleotide primers A1/A2, as shown in Table 1 and described below. PCR products were digested with Taq I to detect mutations, with the wild-type pattern showing 210 bp and 187 bp bands of equal intensity. The absence of one CYP21A2 allele was indicated by a weak 210 bp band, whereas complete absence of this band indicated that both CYP21A2 alleles were absent.
E3Á8 bp detection
No PCR product could be amplified from patients with a homozygous whole-allele deletion or those with a deletion of CYP21A2 exon 3. E3Á8 bp could therefore be ascertained if whole-allele deletion had been excluded.
CYP21A2 point mutation detection
Upstream (fragment 1; exons 1-3) and downstream (fragment 2; exons 3-10) fragments of CYP21A2 were amplified using primer pairs B1/B2 and C1/C2, respectively (Table 1) . 3, 4 PCR products were purified using the Wizard DNA clean-up system (Qiagen), then 5 ml was digested with 10-15 U restriction enzyme for 2-12 h. Mutations were detected in exon 1 (p.Pro30Leu) using Aci I, in exon 6 (p.[Ile236Asn; Val237Glu; Met239Lys]) using Dra III, in exon 8 (p.Gln318Ter) using Pst I, and in exon 8 (p.Arg356Trp) using Aci I. The digests were subjected to electrophoresis on 2.5%-4.0% agarose gels (Table 2) .
PCR conditions
PCR was performed with approximately 200 ng of genomic DNA, 400 mmol/L of each primer, and 2.5 U of Taq in a volume of 50 ml. PCR conditions were 30 cycles of denaturation at 94 C for 20 s, and annealing and extension at 58 C for 90 s (B1/B2) or 68 C for 5 min (C1/C2). PCR conditions for A1/A2 were 35 cycles of denaturation at 94 C for 30 s, annealing at 58 C for 30 s, and extension at 72 C for 30 s. c.290-13A/C > G and p.Ile172Asn were detected using two rounds of PCR. One microliter of the first-round PCR product (fragment 1 for c.290-13A/C > G, fragment 2 for p.Ile172Asn) was used as a template for the second round of PCR with appropriate primer pairs (7/8 for c.290-13 A/C > G and C1/9 for p.Ile172Asn). PCR conditions were 30 cycles of denaturation at 94 C for 30 s, annealing at 58 C (c.290-13 A/C > G) or C for 30 s, in a volume of 50 ml. Five microliters of PCR product were digested with 10-15 U restriction enzyme for 2-12 h (c.290-13A/C > G using Sau3A I; p.Ile172Asn using Ned I) and the digests were subjected to electrophoresis on 3.0%-4.0% agarose gels to detect mutations (Table 2) .
17-OHP assay
Serum 17-OHP levels were determined using a commercial radioimmunoassay (DPC, Los Angeles, CA) with an intra-assay coefficient of variation of 4.0%. The normal value for males was a mean of 1.5 mg/L (95% confidence interval, 0.4-3.5 mg/L). The normal value for females during the follicular stage was a mean of 0.8 mg/L (95% confidence interval, 0.2-2.6 mg/L).
Statistical analyses
Continuous data are presented as means AE standard deviation where appropriate. The variables without normal distributions are expressed as medians plus interquartile ranges. All analyses were carried out using SPSS v.22.0 software (IBM Corp., Armonk, NY).
Results

Mutation detection
Among the 43 patients with 21-OHD, we detected a mutation in 79/86 (91.9%) alleles. The most common mutation was p.Ile172Asn with an allele frequency of 36.0%, followed by c.290-13A/C > G (20.9%), and Del (18.6%). Together, these three mutations made up 75.6% of the total (65/86). The frequencies of the other mutations were p.Pro30Leu (7.0%), p.Gln318Ter (7.0%), p.Val281Leu (4.7%), p.Arg356Trp (2.3%), p.[Ile236Asn; Val237Glu; Met239Lys] (2.3%), and E3Á8 bp (1.2%). No mutation was identified in seven alleles.
Genotype data are reported in Table 3  and Table 4 . In total, 11 alleles (12.8%) in 10 patients carried two different mutations. Among 37 patients with mutations detected on both alleles, the homozygosity frequency was 10.8% (4/37), combined homozygosity was 2.7% (1/37), and compound heterozygosity was 86.5% (32/37). The zygosity status could not be classified for six patients (14.0%) because no mutation was identified on at least one of their alleles. Table 3 and Table 4 show the patients classified by clinical phenotype. In the SW group (n ¼ 9), the most common mutation was Del with an allele frequency of 44.4%, followed by c.290-13A/C > G (38.9%), p.Gln318Ter (5.6%), and E3Á8 bp (5.6%). 7 These mutations, which are all predicted to severely compromise 21-hydroxylase enzymatic activity, made up 77.3% (17/22) of the mutant alleles in the SW group. In the SV group (n ¼ 26), the p.Ile172Asn mutation, which moderately compromises 21-hydroxylase activity, was found in 44.2% of detected alleles, followed by c.290-13 A/C > G with an allele frequency of 17.3% and Del with an allele frequency of 17.3% also. In the NC21-OHD group (n ¼ 8), the common mutations were p.Pro30Leu (allele frequency, 37.5%) and p.Val281Leu (25.0%), both of which only mildly compromise 21-hydroxylase enzymatic activity. All patients in the NC21-OHD group were homozygotes or compound heterozygotes with at least one allele carrying the p.Pro30Leu or p.Val281Leu mutation. Conversely, no SW patients carried p.Pro30Leu or p.Val281Leu, and only one SV patient carried the p.Pro30Leu/ p.Arg356Trp genotype.
Genotype-phenotype correlation
We classified the genotypes into four groups (Null, Group A, Group B, and Group C) 2, [7] [8] [9] [10] [11] according to the extent of 21-hydroxylase enzymatic compromise caused by the mutations ( 
Analysis of NC21-OHD patients
The seven cases with NC21-OHD presented mostly with menstrual disturbance, menopause, hirsutism, and acne. 
Discussion
CYP21A2 mutations in Chinese 21-OHD patients
The current protocol for the rapid genotyping of nine mutations causative of 21-OHD was revised from previous methods 3, 4 and is suitable for clinical applications. The sensitivity of detection was 91.9%, in that 79/86 According to a previous study of 51 Chinese patients (with no NC21-OHD cases) in which the Del mutation was not detected at all, 12 the most common mutation was c.290-13 A/C > G in SW with an allele frequency of 43%. In contrast, in the present study, the most common mutation was Del with an allele frequency of 44.4%, followed by c.290-13A/C > G (38.9%). Previously, p.Ile172Asn (40.7%) was the most frequent mutation in SV patients, followed by c.290-13A/C > G (18.5%); these findings are similar to our own (p.Ile172Asn, 44.2%, c.290-13A/C > G, 17.3%). A study comprising eight SW and 11 SV patients and one NC patient from Taiwan showed that the most 
SW, salt-wasting form; SV, classical simple virilizing form at birth; NC, non-classical form with late-onset symptoms and diagnosis Table 6 . Clinical manifestation and genotype of eight female NC21-OHD patients.
Case no PCO, polycystic ovary prevalent mutation was p.Ile172Asn (27.5%), followed by c.290-13A/C > G (25%), then Del (20%). 13 The genotype of the single NC21-OHD patient was p.Asp183Glu/undetected. In a report of 35 cases from Hong Kong, the most frequent mutations were Del (28.6%) and c.290-13A/ C > G (28.6%), followed by p.Ile172Asn (18.5%).
14 Furthermore, 11 alleles (12.8%) in 10 patients carried two different mutations. This compound heterozygous state probably arose from large gene conversions or recurrent mutation events. The percentage of homozygous genotypes observed in the present study (10.8%) is lower than that reported in the USA (21%), 5 Germany (28%), 7 and Croatia (33%), 15 and much lower than in countries with a high rate of consanguinity such as Iran (50%) 16 and Iraq (50%).
17
Among our Chinese NC21-OHD patients, the most frequent mutation was p.Pro30Leu, with an allele frequency of 37.5% (6/16). In contrast, among Caucasian NC21-OHD patients, the most common mutation was reported to be p.Val281Leu, with an allele frequency of 45%-60%. 18 The frequency of the p.Pro30Leu mutation is very low in parts of the world other than Eastern Asia: 3.6% in France, 19 2.0% in Spain, 20 2.2% in Israel, 21 and 1.7% in Brazil. 22 Japanese patients with NC21-OHD were similar to Chinese patients in that the most common mutation was also p.Pro30Leu with a reported allele frequency of 50.0% (7/14 alleles) in one study 23 and 37.5% (6/16 alleles) in another investigation of Japanese patients. 24 This suggests that the characteristics of CYP21A2 mutations might differ between eastern Asian populations and others.
The mutational distribution was shown to be very similar between Chinese and Japanese populations. 23, 24 Interestingly, however, the p.Val281Leu mutation has not been detected in Japanese patients. 23, 24 One Japanese NC21-OHD patient was heterozygous for p.Val281Leu, but the girl was born in Japan to Brazilian parents. 25 Some investigators have even speculated that NC21-OHD does not occur in Asian populations, or was incorrectly diagnosed, because they had not observed p.Val281Leu. 26 Our finding of p.Val281Leu at a frequency of 25% in Chinese NC21-OHD patients provides evidence to refute this, and suggests a crucial difference between Chinese and Japanese cases that most likely reflects the ethnic differences between these populations. These observations should be confirmed by the molecular analysis of additional Chinese NC21-OHD patients.
The relationship between phenotype and genotype 21-OHD may increase in severity with a rise in the extent of 21-hydroxylase compromise. [7] [8] [9] [10] [11] Mutations causing the complete loss of 21-hydroxylase activity are Del, E3Á8 bp, p.[Ile236Asn; Val237Glu; Met239Lys], p.Gln318Ter, and p.Arg356Trp. c.290-13A/C > G leads to almost no enzymatic activity, while p.Ile172Asn causes a moderate degree of compromise (1%-2% of wildtype activity), and p.Pro30Leu and p.Val281Leu are mild mutations that retain 20%-50% of the wild-type activity. 12, 27 To determine whether genotype can predict phenotype, we classified the genotypes into four groups according to severity. Because 21-OHD is an autosomal recessive disorder, the allele with the less severe mutation has the greater influence on phenotype. We found that our stratification method had a positive predictive value (PPV) of 81.8% (9/11) for predicting SW 21-OHD and a negative predictive value (NPV) of 96.2% (25/26) . The PPV for SV was 94.1% (16/17) and the NPV was 80.0% (16/20) , while the PPV for NC21-OHD was 88.9% (8/9) and the NPV was 100% (28/28 29 showed that the prediction of phenotype from genotype became more difficult in patients who were compound heterozygotes or in those carrying mutations of intermediate severity. Others found the same results in different populations. [30] [31] [32] New et al. 33 reported that 98% of 21-OHD patients had a genotype that corresponded to the hormonal phenotype.
In the present study, we found that the genotype could not be used to predict the phenotype in only five patients. This genotype/phenotype discrepancy may be explained in a number of ways. In the two p.Gln318Ter/c.290-13A/C > G patients, alternative splicing causing variable levels of normal 21-hydroxylase activity might explain why the phenotype was SV not SW. 34 Furthermore, the p.Ile172Asn mutation, which retains 1%-2% of 21-hydroxylase activity, does not always give rise to SV so could explain why the single Del/ p.Ile172Asn case manifested as SW not SV. In the p.Pro30Leu/p.Arg356Trp case, compound heterozygosity may lead to a level of enzymatic activity intermediate between that of p.Pro30Leu and p.Arg356Trp homozygotes, possibly explaining why the case presented as SV not NC21-OHD. Additionally, the presence of unidentified rare mutations modulating the phenotype cannot be excluded. 35 Nevertheless, these genotype-phenotype discrepancies indicate that great caution must be exercised when predicting phenotypes after a prenatal diagnosis using fetal DNA. 36 In conclusion, the genotyping method presented here is practical, suitable for clinical applications, and clearly illustrates the close correlation between genotype and phenotype. We identified many similarities in the mutational spectrum between Chinese and Japanese NC21-OHD patients, but disparity was also noted. Thus, the characterization of NC21-OHD genotypes in different ethnic populations deserves further study.
